A $500mn investment by corporate and philanthropic donors aims to curb respiratory infections and press for their elimination, with backers including payments company Stripe, AI group Anthropic and the OpenAI Foundation.
The initiative, known as Intercept, will target both new drugs and air-cleaning methods, aiming to reduce the toll on health and economic productivity caused by the sometimes deadly viruses.
“The goal is really to make respiratory infections a thing of the past,” said Nan Ransohoff, a co-head of Intercept and Stripe’s head of public goods. While Intercept is “not guaranteed to succeed”, it has “a good shot at moving the needle”, she said.
您已阅读21%（661字），剩余79%（2484字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。